Cargando…

Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube

BACKGROUND: Ovarian cancer is the leading cause of death among gynecologic diseases in Western countries. We have previously identified a miR-200-E-cadherin axis that plays an important role in ovarian inclusion cyst formation and tumor invasion. The purpose of this study was to determine if the miR...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Junzheng, Zhou, Yilan, Ng, Shu-Kay, Huang, Kuan-Chun, Ni, Xiaoyan, Choi, Pui-Wah, Hasselblatt, Kathleen, Muto, Michael G., Welch, William R., Berkowitz, Ross S., Ng, Shu-Wing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473983/
https://www.ncbi.nlm.nih.gov/pubmed/28623900
http://dx.doi.org/10.1186/s12885-017-3417-z
_version_ 1783244387604496384
author Yang, Junzheng
Zhou, Yilan
Ng, Shu-Kay
Huang, Kuan-Chun
Ni, Xiaoyan
Choi, Pui-Wah
Hasselblatt, Kathleen
Muto, Michael G.
Welch, William R.
Berkowitz, Ross S.
Ng, Shu-Wing
author_facet Yang, Junzheng
Zhou, Yilan
Ng, Shu-Kay
Huang, Kuan-Chun
Ni, Xiaoyan
Choi, Pui-Wah
Hasselblatt, Kathleen
Muto, Michael G.
Welch, William R.
Berkowitz, Ross S.
Ng, Shu-Wing
author_sort Yang, Junzheng
collection PubMed
description BACKGROUND: Ovarian cancer is the leading cause of death among gynecologic diseases in Western countries. We have previously identified a miR-200-E-cadherin axis that plays an important role in ovarian inclusion cyst formation and tumor invasion. The purpose of this study was to determine if the miR-200 pathway is involved in the early stages of ovarian cancer pathogenesis by studying the expression levels of the pathway components in a panel of clinical ovarian tissues, and fallopian tube tissues harboring serous tubal intraepithelial carcinomas (STICs), a suggested precursor lesion for high-grade serous tumors. METHODS: RNA prepared from ovarian and fallopian tube epithelial and stromal fibroblasts was subjected to quantitative real-time reverse-transcription polymerase chain reaction (qRT-PCR) to determine the expression of miR-200 families, target and effector genes and analyzed for clinical association. The effects of exogenous miR-200 on marker expression in normal cells were determined by qRT-PCR and fluorescence imaging after transfection of miR-200 precursors. RESULTS: Ovarian epithelial tumor cells showed concurrent up-regulation of miR-200, down-regulation of the four target genes (ZEB1, ZEB2, TGFβ1 and TGFβ2), and up-regulation of effector genes that were negatively regulated by the target genes. STIC tumor cells showed a similar trend of expression patterns, although the effects did not reach significance because of small sample sizes. Transfection of synthetic miR-200 precursors into normal ovarian surface epithelial (OSE) and fallopian tube epithelial (FTE) cells confirmed reduced expression of the target genes and elevated levels of the effector genes CDH1, CRB3 and EpCAM in both normal OSE and FTE cells. However, only FTE cells had a specific induction of CA125 after miR-200 precursor transfection. CONCLUSIONS: The activation of the miR-200 pathway may be an early event that renders the OSE and FTE cells more susceptible to oncogenic mutations and histologic differentiation. As high-grade serous ovarian carcinomas (HGSOC) usually express high levels of CA125, the induction of CA125 expression in FTE cells by miR-200 precursor transfection is consistent with the notion that HGSOC has an origin in the distal fallopian tube. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-017-3417-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5473983
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54739832017-06-21 Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube Yang, Junzheng Zhou, Yilan Ng, Shu-Kay Huang, Kuan-Chun Ni, Xiaoyan Choi, Pui-Wah Hasselblatt, Kathleen Muto, Michael G. Welch, William R. Berkowitz, Ross S. Ng, Shu-Wing BMC Cancer Research Article BACKGROUND: Ovarian cancer is the leading cause of death among gynecologic diseases in Western countries. We have previously identified a miR-200-E-cadherin axis that plays an important role in ovarian inclusion cyst formation and tumor invasion. The purpose of this study was to determine if the miR-200 pathway is involved in the early stages of ovarian cancer pathogenesis by studying the expression levels of the pathway components in a panel of clinical ovarian tissues, and fallopian tube tissues harboring serous tubal intraepithelial carcinomas (STICs), a suggested precursor lesion for high-grade serous tumors. METHODS: RNA prepared from ovarian and fallopian tube epithelial and stromal fibroblasts was subjected to quantitative real-time reverse-transcription polymerase chain reaction (qRT-PCR) to determine the expression of miR-200 families, target and effector genes and analyzed for clinical association. The effects of exogenous miR-200 on marker expression in normal cells were determined by qRT-PCR and fluorescence imaging after transfection of miR-200 precursors. RESULTS: Ovarian epithelial tumor cells showed concurrent up-regulation of miR-200, down-regulation of the four target genes (ZEB1, ZEB2, TGFβ1 and TGFβ2), and up-regulation of effector genes that were negatively regulated by the target genes. STIC tumor cells showed a similar trend of expression patterns, although the effects did not reach significance because of small sample sizes. Transfection of synthetic miR-200 precursors into normal ovarian surface epithelial (OSE) and fallopian tube epithelial (FTE) cells confirmed reduced expression of the target genes and elevated levels of the effector genes CDH1, CRB3 and EpCAM in both normal OSE and FTE cells. However, only FTE cells had a specific induction of CA125 after miR-200 precursor transfection. CONCLUSIONS: The activation of the miR-200 pathway may be an early event that renders the OSE and FTE cells more susceptible to oncogenic mutations and histologic differentiation. As high-grade serous ovarian carcinomas (HGSOC) usually express high levels of CA125, the induction of CA125 expression in FTE cells by miR-200 precursor transfection is consistent with the notion that HGSOC has an origin in the distal fallopian tube. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-017-3417-z) contains supplementary material, which is available to authorized users. BioMed Central 2017-06-17 /pmc/articles/PMC5473983/ /pubmed/28623900 http://dx.doi.org/10.1186/s12885-017-3417-z Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Yang, Junzheng
Zhou, Yilan
Ng, Shu-Kay
Huang, Kuan-Chun
Ni, Xiaoyan
Choi, Pui-Wah
Hasselblatt, Kathleen
Muto, Michael G.
Welch, William R.
Berkowitz, Ross S.
Ng, Shu-Wing
Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube
title Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube
title_full Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube
title_fullStr Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube
title_full_unstemmed Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube
title_short Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube
title_sort characterization of microrna-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473983/
https://www.ncbi.nlm.nih.gov/pubmed/28623900
http://dx.doi.org/10.1186/s12885-017-3417-z
work_keys_str_mv AT yangjunzheng characterizationofmicrorna200pathwayinovariancancerandserousintraepithelialcarcinomaoffallopiantube
AT zhouyilan characterizationofmicrorna200pathwayinovariancancerandserousintraepithelialcarcinomaoffallopiantube
AT ngshukay characterizationofmicrorna200pathwayinovariancancerandserousintraepithelialcarcinomaoffallopiantube
AT huangkuanchun characterizationofmicrorna200pathwayinovariancancerandserousintraepithelialcarcinomaoffallopiantube
AT nixiaoyan characterizationofmicrorna200pathwayinovariancancerandserousintraepithelialcarcinomaoffallopiantube
AT choipuiwah characterizationofmicrorna200pathwayinovariancancerandserousintraepithelialcarcinomaoffallopiantube
AT hasselblattkathleen characterizationofmicrorna200pathwayinovariancancerandserousintraepithelialcarcinomaoffallopiantube
AT mutomichaelg characterizationofmicrorna200pathwayinovariancancerandserousintraepithelialcarcinomaoffallopiantube
AT welchwilliamr characterizationofmicrorna200pathwayinovariancancerandserousintraepithelialcarcinomaoffallopiantube
AT berkowitzrosss characterizationofmicrorna200pathwayinovariancancerandserousintraepithelialcarcinomaoffallopiantube
AT ngshuwing characterizationofmicrorna200pathwayinovariancancerandserousintraepithelialcarcinomaoffallopiantube